Breast Cancer Market - Trends Forecast Till 2028

Breast Cancer Market By Drugs Class (Chemotherapy Drugs, Hormone Therapy, Targeted Therapy), Surgery (Lumpectomy, Mastectomy, Reconstructive Surgery), Phase (PHASE I, PHASE II,. PHASE III, PHASE IV), Therapies (Radiation Therapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others), End Users (Oncology Centers, Hospitals, Specialty Centers, Academic Research Institutes And Laboratories, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-BCM-29

Format:  

Number of Pages: 179

Domain: Healthcare

Breast Cancer Market – Trends Forecast Till 2028

The global breast cancer market is anticipated to reach USD 31.5 billion by 2020 growing at a CAGR of 9.6% during the forecasting period, 2020-2028. Breast cancer is the result of uncontrolled cell division of breast cells, the most common cells of breast lobule and ducts. It may also affect fatty or connective tissues within the breasts. Breast cancer is the second most common type of cancer worldwide, affecting nearly 2 million women. Factors such as the rising geriatric population along with cancer incidences, rising focuses on research & development in the medical field for cancers is another factor driving the market for the global breast cancer market

Breast Cancer Market – Trends Forecast Till 2028

The global breast cancer market is segmented into drug class, surgery, therapies, end-users, and geography.

Drugs Class segment is segmented into Chemotherapy Drugs, Hormone Therapy, Targeted Therapy. 

The surgery segment is segmented into Lumpectomy, Mastectomy, and Reconstructive Surgery. The reconstructive surgery segment is segmented into Tissue Flap Procedures, Implants. Tissue Flap Procedure is further segmented into Latissimus Dorsi Flap, Transverse Rectus Abdominis Muscle (TRAM) Flap, Deep Inferior Epigastric Artery Perforator (Diep) Flap, and Gluteal Free Flap.

 Phase segment is segmented into PHASE I, PHASE II, PHASE III, and PHASE IV

The therapies segment is segmented into Radiation Therapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others. Radiation Therapy has been segmented into External-Beam Radiation Therapy, Intra-Operative Radiation Therapy, Brachytherapy, Proton Therapy, Intensity-Modulated Radiation Therapy, Partial Breast Irradiation, Neoadjuvant Radiation Therapy, and Adjuvant Radiation Therapy. Radiation Therapy has been segmented on the basis of the schedule into After a Mastectomy, After a Lumpectomy. Targeted Therapy has been further segmented into Trastuzumab, Pertuzumab (PERJETA), Neratinib (NERLYNX). Hormonal Therapy has been further segmented into Aromatase Inhibitors (AIS), Tamoxifen, and Ovarian Suppression. Ovarian Suppression has been further segmented on the basis of methods into Gonadotropin or Luteinizing Hormone-Releasing and Ovaries Removal.

End Users segment is segmented into Oncology Centers, Hospitals and Specialty Centers, Academic Research Institutes and Laboratories and Others

Geographically, the global breast cancer market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

North America region is the largest contributor to the breast cancer market in the forecast period 2020-2028.

Key players in the global breast cancer market are Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services Llc, Celgene Corporation, Astellas Pharma Inc., Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Astellas Pharma, Abbvie, Inc., Genentech, Inc., Macrogenics Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed among others.

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2017, Cynvenio Biosystems, Inc has launched a second-generation PD-L1 expression test. This new blood test helps in offering improved analytic performance as compared to the first-generation PD-L1 test and has high sensitivity.
  • In 2017, Cynvenio Biosystems Inc has released a liquid biopsy monitoring service named ClearID Total Insight Breast Cancer which is used for patients helps in treating cancer-related problems

Available Customizations

In addition to the market data for the breast cancer market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

 

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the breast cancer market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global breast cancer market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the breast cancer market.

The primary Respondent breakdown is provided below:

Breast Cancer Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the breast cancer market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the breast cancer market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 31.5 billion

Growth Rate

CAGR of 9.6% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Drug Class, Surgery, Therapies, End Users and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services Llc, Celgene Corporation, Astellas Pharma Inc., Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Astellas Pharma, Abbvie, Inc., Genentech, Inc., Macrogenics Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed among others

Available Customization 

In addition to the market data for the breast cancer market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

 

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.